stella
beta
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia — Stella
Recruiting
Back to Myelodysplastic Syndrome trials
Trial locations
(2 sites)
South Korea
Local Institution - 0001, Seoul
Novotech Laboratory Korea Co., Ltd., Seoul
View full record on ClinicalTrials.gov